Back to Search
Start Over
FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS
- Source :
- Multiple Sclerosis and Related Disorders; 20220101, Issue: Preprints
- Publication Year :
- 2022
-
Abstract
- :Since the introduction of oral disease-modifying agents (DMA) in 2010, the treatment options for multiple sclerosis (MS) have changed significantly. There is limited information regarding the factors associated with switching to oral DMA among prevalent injectable DMA users.
Details
- Language :
- English
- ISSN :
- 22110348
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- Multiple Sclerosis and Related Disorders
- Publication Type :
- Periodical
- Accession number :
- ejs59051735
- Full Text :
- https://doi.org/10.1016/j.msard.2022.103703